Develops and manufactures agricultural and noncrop products

Sangamo BioSciences is a clinical stage biopharmaceutical company involved in gene therapy that is researching ways of commercializing Zinc finger nucleases which modify a cell's DNA at an exact location thereby correcting or disrupting a specific gene. Sangamo BioSciences' lead therapy, SB-728, is a potential functional cure for HIV/AIDS. SB-728 works by removing some of the immune cells from the patient's blood that HIV attacks. The blood is sent to a lab which applies the SB-728 treatment to the patient's immune cells. The treatment removes the protein gateway on the immune cells that HIV needs to infect. The treated cells are then infused back into the patient whereby they reproduce and take over as HIV attacks and kills the non-treated cells. The treated, resistant cells thereby control the HIV infection and thus cures the patient from opportunistic infections that result from HIV. Recent published data further support the company's ongoing progress which has been described as "a major step toward immunological functional control of HIV."

LifeScan manufactures and markets blood glucose monitoring systems. The company’s product portfolio includes blood glucose meters, test strips, lancing devices, and diabetes management software solutions, hospital meters, data management systems, glucose control solutions, and linearity test kits. Additionally, the company provides pre-installation project management, installation, and post installation support services, including on-site and on-line training programs through authorized distributors such as doctors, pharmacists, and diabetes educators. Lifescan was founded in 1981 and is headquartered in Milpitas, California.  The company currently operates as a subsidiary of Johnson & Johnson and has facilities in Inverness, Scotland; Burnaby, British Columbia, Canada; and Cabo Rojo, Puerto Rico.

Proyecto de Biomedicina CIMA SL is a holding company engaged in the provision of product licensing and intellectual property rights management services. It holds patents generated by the Centro de Investigacion Medica Aplicada, which have indications across the clinical fields of oncology, hepatology, dermatology, and gene therapy. The company was founded in June 2003 and is headquartered in Pamplona, Spain.

ChromaGenics BV operates as a biotechnology firm. It uses genetics and biochemistry to characterize and modify chromatin structure and chromatin-modifying proteins for the sake of health care, pharmaceuticals and agricultural biotechnology. The company was founded by Arie Otte, and Niek Roosdorp is headquartered in Amsterdam, the Netherlands.

Eisbach Bio is a biotechnology company that creates new drugs that target molecular vulnerabilities in cancer genomes. Screening and cellular platforms are yielding first-in-class inhibitors to directly target the key vulnerability found in genetically defined tumors. It is founded in 2019 and is based in Martinsried, Bavaria.

NEL ASA operates as a hydrogen company, which engages in the provision of solutions to produce, store and distribute hydrogen from renewable energy. Its hydrogen solutions cover the value chain from hydrogen production technologies to manufacturing of hydrogen fueling stations. It operates through the following segments: Nel Hydrogen Fueling and Nel Hydrogen Electrolyser. The Nel Hydrogen Fueling segment is involved in manufacturing of hydrogen fueling stations providing fuel cell electric vehicles with the same fast fueling and long range as conventional fossil fuel vehicles. The Nel Hydrogen Electrolyser segment manages a supplier of hydrogen production equipment and plants based on alkaline and water electrolyser technology. The company was founded by Erik Anders Lönneborg and Praveen Sharma in 1927 and is headquartered in Oslo, Norway.

Ramot at Tel Aviv University Ltd. operates as a technology transfer company of Tel Aviv University (TAU). It provides legal and commercial frameworks for inventions made by TAU faculty, students, and researchers. The firm licenses the university's intellectual property to third parties through agreements; facilitates collaborative research partnerships between business partners and TAU researchers; establishes a company; and forms joint ventures that promote TAU technologies. The company was founded in 1973 and is headquartered in Tel Aviv, Israel.

BC Cancer Agency provides healthcare services. The firm serves for hereditary cancer, indigenous cancer care, interpreters, and psychiatry. Its services include assessment and follow-up library, nutrition services, pain and symptom management, patient and family counselling, PET functional imaging, primary care, screening programs, and speech-language pathology. The company was founded on November 5, 1938 and is headquartered in Vancouver, Canada.

Massachusetts General Hospital was established to provide care to Boston's sick, regardless of socioeconomic status—an innovative idea in 1811. In the words of their founder, John Warren, MD, “When in distress, every man becomes their neighbor.” They subsequently became the first teaching hospital for Harvard University’s new medical school and have been redefining excellence in healthcare ever since. They have remained at the forefront of medicine by fostering a culture of collaboration, pushing the boundaries of medical research, educating the brightest medical minds and maintaining an unwavering commitment to the diverse community they were created to serve. They believe that because of diversity they excel, through inclusion they respect their community, and with a keen focus on equity they serve, heal, educate and innovate at the highest levels. Their first priority is the well-being of their patients—near and far. As a team they are able to maintain a singular focus on providing the highest quality, most compassionate care to each and every patient.

SBI Biotech mainly focuses on dendritic cell platform-based innovative drug development. As an R&D-type bio-venture company, we do not have abundant human resource like in the case of general pharmaceutical companies and we mainly focus on our activity in the early stages of drug development. Particularly, our biggest hurdle is the clinical studies / clincal trials which we need huge budgets to support our clinical trials on human to test drug safety and efficacy. We have been trying to utilize our human and financial resources efficiently by early licensing of our pipelines in the preclinical stage, instead of performing the clinical trials by our own. For the early stage licensing, we have tried to provide excellent products by the world-leading research team with the expertise in dendritic cell manipulation. We have successfully proven the feasibility of the business model since we succeeded in licensing of our early stage dendritic cells targeting antibody, anti-ILT7 antibody to MedImmune. We will continue our efforts in early licensing activity by our highly competitive research team.

Chengdu Genomeer Biotechnology Co., Ltd., established on 2017-08-28, Business scope includes medical research and experimental development;R&D and technology transfer of biological agents,technical consulting;Biotechnology Testing Services;Medical device research and development;Research and development of daily chemical products;Import and export of goods and technology;Sales:Biotechnology Experimental Reagents,Biotechnology experiment consumables(The above range does not include national laws,Administrative regulations,Items restricted or prohibited by the State Council,Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).

Chengdu Zhonglian Biotechnology Co., Ltd., established on 2012-07-11, Business scope includes biotechnology,Research and development of chemical technology and provide technical services,technology transfer(No pre-licensed items,Post-licensing projects operate on the basis of licenses or approval documents);Sales:Chemical Reagents and Auxiliaries(Free of Hazardous Chemicals),Instrumentation,Equipment,electronic product,Computers and Auxiliary Equipment,communication device(Excluding wireless broadcasting and television transmitting equipment and satellite ground receiving equipment),medical instrumentsIkind,metallic material(No precious metals),Glass product,plastic products,Office Supplies,daily necessities;Import and export,Technology Import and Export;to develop,Sell ​​computer software and hardware and provide technical consultation,technology transfer;Information Technology Consulting Services;Computer System Integration Services;Business Management Consulting;Enterprise Marketing Planning;Corporate Image Planning;marketing planning;business inquiries(Does not include investment advice);Market information consultation(Does not include investment advice);market research.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).

BASF Plant Science is a subsidiary of BASF in which all plant biotechnology activities are consolidated. The GmbH was founded in 1998 and employs approximately 700 people at 6 different locations worldwide. The headquarters of BASF Plant Science is located in Research Triangle Park (North Carolina, USA). Plant Science has research sites in the US, Canada and Europe. At these locations the company is mainly developing genetically modified seeds.

Sigma Aldrich Co. Ltd. engages in the science and technology company. Its products include analytical standards, gas chromatography, spectroscopy, acids and bases, catalysis and inorganics, organometallics, solvents, antibodies, biochemical and reagents, cell biology, microbiology, and polymer sciences. It also offers basic research, product and process development, manufacturing and production, and regulatory compliance services. The company was founded on December 10, 1987 and is headquartered in Gillingham, the United Kingdom.

The Indian Institutes of Technology (IITs) are autonomous public institutes of higher education, located in India. They are governed by the Institutes of Technology Act, 1961 which has declared them as institutions of national importance and lays down their powers, duties, and framework for governance. The Institutes of Technology Act, 1961 lists twenty-three institutes. Each IIT is autonomous, linked to the others through a common council (IIT Council), which oversees their administration. The Minister of Human Resource Development is the ex officio Chairperson of the IIT Council. As of 2018, the total number of seats for undergraduate programs in all IITs is 11,279.

Primorigen Biosciences, Inc. operates as a research and manufacturing company. Its versatile coated microcarrier platform provided superior cell proliferation and seeding efficiency in customer trials while reducing preparation from multiple days to minutes. The company was founded by Charles Oehler and Thomas J. Burke in 2005 and is headquartered in Madison, WI.